杜拉鲁肽
医学
安慰剂
内科学
2型糖尿病
糖尿病
糖化血红素
恶心
不利影响
胃肠病学
耐受性
二甲双胍
内分泌学
胰岛素
利拉鲁肽
替代医学
病理
作者
Bo Zhang,Zhifeng Cheng,Ji Chen,Xin Zhang,Dexue Liu,Hongwei� Jiang,Guoqing Ma,Xiaoyun Wang,Shenglian Gan,Juan Sun,Ping Jin,Jianjun Yi,Bimin Shi,Jianhua Ma,Shandong Ye,Guixia Wang,Linong Ji,Xuejiang Gu,Ting Yu,Pei An
出处
期刊:Diabetes Care
[American Diabetes Association]
日期:2023-11-09
卷期号:47 (1): 160-168
被引量:67
摘要
In Chinese patients with type 2 diabetes, mazdutide dosed up to 6 mg was generally safe and demonstrated clinically meaningful HbA1c and body weight reductions.
科研通智能强力驱动
Strongly Powered by AbleSci AI